Attovia Therapeutics, Inc. (ATTO): Form 8-K filed 2026-11-09
- Accepted by EDGAR
- 2026-11-09 16:10 ET
- Event date
- 2026-11-09
- Accession no.
- 0001193125-26-453592
- Original filing
- SEC EDGAR filing index
Items reported
- Item 2.02: Results of Operations and Financial Condition
The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed". - Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | atto-20261109.htm |
| EX-99.1 | EX-99.1 | atto-ex99_1.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.